# US Veterinary Medicine Market

> US Veterinary Medicine Market Research Report: By Animal Type (Domesticated, Companion), By Product (Drugs, Vaccines), By Route of Administration (Oral, Parental) and By Distribution Channel (Veterinary Hospitals & Clinics, Retail Stores, Online Pharmacies) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.62%
- **2024:** $ 8.87 Billion
- **2025:** $ 9.37 Billion
- **2035:** $ 16.18 Billion
- **Key Players:** Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Virbac (FR), Ceva Santé Animale (FR), Dechra Pharmaceuticals (GB), Vetoquinol (FR), Phibro Animal Health (US)

**Report ID:** MRFR/Pharma/11430-HCR · **Pages:** 100 · **Author:** Vikita Thakur & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-veterinary-medicine-market-12955

---

## Market Summary

## **US Veterinary Medicine Market Overview**

As per MRFR analysis, the US Veterinary Medicine Market Size was estimated at 7.2 (USD Billion) in 2023. The US Veterinary Medicine Market Industry is expected to grow from 8.12(USD Billion) in 2024 to 14.56 (USD Billion) by 2035. The US Veterinary Medicine Market CAGR (growth rate) is expected to be around 5.452% during the forecast period (2025 - 2035).

### **Key US Veterinary Medicine Market Trends Highlighted**

The US Veterinary Medicine Market is experiencing notable trends driven by several factors. Increasing pet ownership in the US is one significant driver, as more households consider pets as family members, leading to a heightened demand for veterinary services and products. Additionally, the growing awareness of animal healthcare and the importance of preventive care are prompting pet owners to invest more in the wellbeing of their animals. There is also an upswing in pet insurance adoption, which is contributing to the market's growth by making veterinary services more accessible.

Recent trends show a rising preference for advanced veterinary technologies, including telemedicine and digital health records, which enhance the connection between veterinarians and pet owners.This shift not only improves healthcare delivery but also streamlines scheduling and reduces wait times for patients. Moreover, the shift towards a more holistic approach to pet care is gaining momentum, with emphasis on natural and organic products, including alternative therapies, which reflect changing consumer preferences. Opportunities within the market are vast, especially for new product innovations and services aimed at improving pet healthcare.

The demand for specialized treatments, such as oncology and orthopedics, is on the rise, presenting avenues for growth. Moreover, addressing the aging pet population with targeted health solutions can enable market players to cater to specific needs.As technology rapidly evolves, integrating artificial intelligence and machine learning into veterinary services can create efficiencies and improve diagnostics. Overall, the US [Veterinary Medicine Market](../../../reports/veterinary-medicine-market-844) is poised for dynamic evolution, driven by changing consumer behaviors and technological advancements.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Veterinary Medicine Market Drivers**

### **Increasing Pet Ownership**

The trend of rising pet ownership in the United States is a significant driver for the US Veterinary Medicine Market Industry. According to the American Pet Products Association, 70% of U.S. households, or about 90.5 million families, owned a pet in 2021. This is a notable increase from previous years, leading to a larger market for veterinary services and medications as more households invest in the health and wellness of their pets. As pet owners become more aware of preventative healthcare, including vaccinations and routine check-ups, the demand for veterinary services is expected to continue rising.

This demographic shift is further supported by improved societal attitudes toward pet care, where pet owners are increasingly treating their animals as family members. With established organizations, such as the American Veterinary Medical Association, advocating for animal health, there's a growing infrastructure supporting veterinary practices and, consequently, the overall market growth in veterinary medicine in the U.S.

### **Rising Awareness of Animal Health**

There is a growing awareness among pet owners in the United States regarding the importance of animal health and wellness, significantly impacting the US Veterinary Medicine Market Industry. Research indicates that around 63% of pet owners in the U.S. regularly seek veterinary care, an increase of approximately 10% over the last five years. This shift is largely influenced by educational campaigns led by various animal welfare organizations and veterinary associations emphasizing preventative care.

Such organizations, including the American Animal Hospital Association, have collaborated to provide resources and information that empower pet owners to make informed decisions about their pets' healthcare needs. This increased awareness is correlated with an overall uptick in pet medical spending, fostering a robust market environment for veterinary medicines and services.

### **Technological Advancements in Veterinary Medicine**

The integration of advanced technologies in veterinary medicine is rapidly transforming the US Veterinary Medicine Market Industry. Notably, the use of telemedicine has seen a soaring adoption rate; after the COVID-19 pandemic, telehealth visits for pets increased by over 30% across the nation. Leading veterinary organizations, such as the North American Veterinary Community, have emphasized the significance of digital health tools and online consultations in providing effective care to pets.

These technological advancements not only improve access to veterinary services, especially in rural areas but also enhance the efficiency and accuracy of diagnoses and treatments. The implementation of innovative diagnostic tools, such as artificial intelligence-driven imaging and lab technologies, is expected to drive market growth as more veterinary practices leverage these tools to improve and expedite patient care.

## **US Veterinary Medicine Market Segment Insights**

### **Veterinary Medicine Market Animal Type Insights**

The US Veterinary Medicine Market is experiencing significant growth, particularly within the Animal Type segmentation, which includes categories such as Domesticated and Companion animals. The increasing awareness regarding pet health and wellness has led to a rising demand for veterinary services across various animal types. The Companion segment is particularly noteworthy as it often represents a major portion of the market, fueled by the emotional connection humans have with their pets. In the age of urbanization, households are increasingly adopting pets, considering them as part of the family, which enhances the need for medical care and services.

This trend is supported by data indicating that the majority of pet owners now consider regular veterinary visits essential for maintaining their animals’ health. Meanwhile, the Domesticated segment encompasses a wider variety of animals typically raised for food production, including livestock. This segment plays a crucial role in ensuring food safety and animal welfare, driven by rising consumer awareness regarding the conditions under which food animals are raised and treated. The growing population in the US also contributes to the demand for veterinary services in both segments, as more animals require care.

Additionally, advancements in veterinary pharmaceuticals and technologies provide better treatment options for both Companion and Domesticated species, thus significantly enhancing animal health outcomes. Factors like the increasing involvement of veterinary professionals in Research and Development also aim to lead to innovative solutions, addressing the distinct needs of different animal types. Consequently, the US Veterinary Medicine Market data reflects a dynamic landscape with ample opportunities for growth driven by demographic changes, a better understanding of animal rights, and the pivotal role of veterinary services in maintaining the health of various animal populations.

All these aspects make the Animal Type segment a vital component of the overall market, demonstrating its significance in shaping the future of veterinary medicine in the United States. Overall, the growth in this sector is expected to be supported by ongoing legislative changes and public efforts towards enhancing the overall welfare of both Companion and Domesticated animals, thus leading to a more robust Veterinary Medicine Market industry in the coming years.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Veterinary Medicine Market Product Insights**

The US Veterinary Medicine Market is a diverse field focusing on the health and welfare of animals, with a notable emphasis on the Product segment, which includes Drugs and Vaccines. Drugs play a vital role in treating various diseases and managing health conditions in pets and livestock, accounting for a substantial portion of veterinary medicine. This segment is driven by the increasing awareness of animal health, the rising costs associated with veterinary care, and the pet ownership trend, which highlights the importance of maintaining pet health.

Vaccines are equally significant, as they provide essential preventative care, protecting animals from infectious diseases and contributing to public health by minimizing zoonotic disease transmission. The rising prevalence of diseases affecting animals is expected to drive the demand for veterinary vaccines, allowing for enhanced health management strategies. The interplay between these products highlights a growing need for innovation in drug formulation and vaccine development tailored to the unique health challenges faced by animals in the US.

Overall, the Product segment is pivotal in ensuring better animal health outcomes while reinforcing the economic importance of the US Veterinary Medicine Market.

### **Veterinary Medicine Market Route of Administration Insights**

The Route of Administration segment within the US Veterinary Medicine Market has gained significant attention due to its crucial role in the delivery of medications to animals. It consists primarily of Oral and Parenteral routes, each serving specific needs and situations in veterinary care. The oral route is widely preferred due to its ease of administration, compliance, and the ability to deliver medications in a non-invasive manner, making it particularly suitable for long-term treatment plans in companion animals.

In contrast, the parenteral route, which includes injections, emerges as a dominant option for situations requiring rapid therapeutic effects or in cases where oral administration is not feasible.

Trends in this segment indicate a growing demand for innovative drug formulations and delivery systems that enhance efficacy and convenience for both veterinarians and pet owners. The market growth is further driven by an increasing focus on pet health, advancements in veterinary pharmaceuticals, and a rise in pet ownership across the country. Challenges in this segment include ensuring ease of use and managing the pain associated with injectable medications, presenting opportunities for companies to develop improved delivery systems. Overall, the Route of Administration segment plays an essential role in shaping the US Veterinary Medicine Market landscape.

### **Veterinary Medicine Market Distribution Channel Insights**

The Distribution Channel segment of the US Veterinary Medicine Market plays a crucial role in ensuring that veterinary products are accessible to pet owners and livestock producers alike. Veterinary Hospitals and Clinics are essential, serving as primary points for diagnosis and treatment, where animal health professionals prescribe medication and provide necessary care. Retail Stores are also significant in this segment, catering to pet owners with a variety of over-the-counter veterinary products, making it easy for consumers to find what they need locally.

Online Pharmacies have been increasingly gaining traction, particularly due to the convenience of purchasing medications from home, especially for those who may live in remote areas. This shift to online shopping is supported by a growing trend towards digital health solutions in the wake of the COVID-19 pandemic. Each subsector possesses unique strengths, with online platforms often providing competitive pricing and home delivery, while physical stores offer immediacy and personalized customer service. The overall US Veterinary Medicine Market segmentation underscores the importance of these channels in meeting diverse consumer needs and enhancing overall market growth.

The evolving landscape presents both challenges and opportunities, particularly with the integration of technology in traditional purchasing channels, ensuring that the distribution of veterinary medicines continues to adapt to consumer preferences.

## **US Veterinary Medicine Market Key Players and Competitive Insights**

The US Veterinary Medicine Market is characterized by a dynamic competitive landscape that has been shaped by a combination of innovation, regulatory factors, and evolving consumer preferences. The market is driven by the growing emphasis on animal health and welfare, alongside rising pet ownership rates. As veterinarians and pet owners increasingly recognize the importance of preventative healthcare and effective treatments, numerous companies strive to differentiate their products and services within a crowded marketplace. This has led to increased investment in research and development, facilitating the introduction of advanced pharmaceuticals, vaccines, and diagnostics.

Furthermore, the demand for integrated care solutions and practices that focus on holistic well-being plays a significant role in shaping the competitive environment. Companies actively engage in mergers and acquisitions in order to expand their product lines and strengthen their presence within the market, enhancing their competitive advantage and aligning with the overarching market trends of innovation and quality.

In the context of the US Veterinary Medicine Market, Zoetis stands out due to its unparalleled commitment to animal health, bolstered by an extensive portfolio of products that includes vaccines, diagnostics, and therapeutics tailored for both food-producing and companion animals. Recognized as a leader in the industry, Zoetis leverages its strong research and development foundation to continually introduce new and effective solutions that address the evolving needs of veterinarians and pet owners alike. The company's robust distribution network ensures widespread availability of its products, further solidifying its market position.

Zoetis’s strength lies not only in innovation but also in its ability to respond quickly to market demands, reinforcing customer loyalty through veterinarian partnerships and educational initiatives that heighten awareness around animal healthcare.

MediVet Biologics, while smaller in scale, has carved out a notable niche in the US Veterinary Medicine Market through its unique focus on regenerative medicine and biologics. The company specializes in providing advanced therapies, particularly using cutting-edge stem cell technology and platelet-rich plasma applications to treat a variety of conditions affecting pets and horses. MediVet Biologics emphasizes the importance of minimally invasive treatment options, appealing to a growing demographic that values less conventional approaches to animal healthcare. The company has built strong relationships with veterinary practitioners and academic institutions, enhancing its credibility and presence within the market.

Through strategic collaborations and an emphasis on education for veterinary professionals, MediVet Biologics has successfully positioned itself as a pioneer in the growing field of regenerative medicine, contributing to its competitive edge in a rapidly evolving sector. Additionally, the company continues to explore opportunities for mergers and acquisitions to expand its reach and improve its product offerings.

### **Key Companies in the US Veterinary Medicine Market Include**

## **US Veterinary Medicine Market Industry Developments**

Recent developments in the US Veterinary Medicine Market reflect significant activity among key players such as Zoetis, Merck Animal Health, and Elanco Animal Health. In October 2023, Zoetis announced the launch of a new portfolio of mRNA-based vaccines aimed at enhancing disease resistance in livestock. The market is also witnessing a noteworthy surge in investment; for instance, MediVet Biologics received funding in September 2023 to expand its regenerative medicine offerings for pets.

In terms of mergers and acquisitions, Merck Animal Health completed the acquisition of a biotechnology firm specializing in animal health in August 2023, strengthening its position in the diagnostics sector. Meanwhile, in July 2023, Elanco Animal Health announced its merger with a veterinary service provider to enhance its service capabilities across the US.

The valuation of companies has seen a marked increase due to rising pet ownership, with IDEXX Laboratories reporting revenue growth attributed to strong demand for diagnostic products. Over the last couple of years, heightened focus on animal welfare and advances in veterinary technology continue to reshape the landscape of the US Veterinary Medicine Market.

## **US Veterinary Medicine Market Segmentation Insights**

### **Veterinary Medicine Market Animal Type Outlook**

### **Veterinary Medicine Market Product Outlook**

### **Veterinary Medicine Market Route of Administration Outlook**

### **Veterinary Medicine Market Distribution Channel Outlook**

- Veterinary Hospitals & Clinics
- Retail Stores
- Online Pharmacies

## Market Drivers

### Rising Pet Ownership Rates

The veterinary medicine market experiences a notable boost due to the increasing rates of pet ownership across the United States. As more households welcome pets, the demand for veterinary services and products escalates. According to recent data, approximately 67% of U.S. households own a pet, which translates to around 85 million families. This surge in pet ownership correlates with a heightened need for veterinary care, including routine check-ups, vaccinations, and emergency services. Consequently, the veterinary medicine market is likely to see sustained growth as pet owners prioritize their animals' health and well-being. Furthermore, the trend of adopting pets from shelters and rescues may also contribute to the demand for veterinary services, as these animals often require immediate medical attention and ongoing care.

### Growing Awareness of Animal Health

There is a rising awareness among pet owners regarding the importance of animal health, which significantly impacts the veterinary medicine market. Educational campaigns and increased access to information have empowered pet owners to make informed decisions about their pets' health. This heightened awareness has led to a greater emphasis on preventive care, vaccinations, and regular veterinary visits. As a result, the veterinary medicine market is witnessing a shift towards more proactive health management strategies. Reports indicate that spending on preventive care has increased by approximately 20% over the past few years, reflecting a cultural shift in how pet owners approach their animals' health. This trend is likely to continue, further driving demand for veterinary services and products.

### Increase in Pet Insurance Adoption

The veterinary medicine market is experiencing a transformation due to the increasing adoption of pet insurance among pet owners. As more individuals recognize the financial benefits of insuring their pets, the demand for veterinary services is likely to rise. Pet insurance can alleviate the financial burden associated with unexpected medical expenses, encouraging pet owners to seek veterinary care more readily. Recent statistics indicate that approximately 30% of pets in the U.S. are now insured, a figure that has been steadily increasing. This trend not only enhances the accessibility of veterinary services but also promotes a culture of preventive care, as insured pet owners are more inclined to pursue regular check-ups and vaccinations. Consequently, the veterinary medicine market stands to benefit from this growing trend.

### Advancements in Veterinary Technology

Technological innovations play a pivotal role in shaping the veterinary medicine market. The integration of advanced diagnostic tools, telemedicine, and electronic health records enhances the efficiency and effectiveness of veterinary practices. For instance, the use of telemedicine allows veterinarians to consult with pet owners remotely, thereby expanding access to care. Moreover, the market for veterinary diagnostic equipment is projected to reach approximately $2.5 billion by 2026, indicating a robust growth trajectory. These advancements not only improve patient outcomes but also streamline operations within veterinary practices. As technology continues to evolve, the veterinary medicine market is expected to adapt, leading to improved service delivery and increased client satisfaction.

### Regulatory Developments in Veterinary Medicine

The veterinary medicine market is influenced by various regulatory developments that shape the landscape of veterinary practices. Changes in regulations regarding drug approvals, animal welfare standards, and veterinary licensing can have profound effects on the industry. For instance, the introduction of new guidelines for the use of antibiotics in livestock has prompted veterinarians to adopt alternative treatment methods, thereby impacting the market for veterinary pharmaceuticals. Additionally, compliance with evolving regulations necessitates ongoing education and training for veterinary professionals, which can drive demand for specialized services. As the regulatory environment continues to evolve, the veterinary medicine market must adapt to ensure compliance while maintaining high standards of care.

## Future Outlook

The [Veterinary Medicine Market](https://www.marketresearchfuture.com/reports/veterinary-medicine-market-844) is projected to grow at a 5.62% CAGR from 2025 to 2035, driven by increasing pet ownership, advancements in veterinary technology, and rising awareness of animal health.

**New opportunities:**

- Development of telemedicine platforms for remote consultations Expansion of personalized veterinary pharmaceuticals Implementation of AI-driven diagnostic tools for early disease detection

By 2035, the veterinary medicine market is expected to be robust, reflecting sustained growth and innovation.

## Segment Insights

### By Animal Type: Companion (Largest) vs. Domesticated (Fastest-Growing)

In the US veterinary medicine market, the Companion segment holds the largest market share, driven by the growing population of pets and increasing spending on their health care. This dominant group includes services like routine check-ups, vaccinations, and preventive care. Meanwhile, the Domesticated segment, while smaller, is rapidly gaining traction as more owners seek veterinary services tailored to farm animals and livestock, reflecting a growing awareness of animal health and wellness. The growth trends for the segments are influenced by several factors, including changing consumer attitudes towards pet care and advancements in veterinary medicine. Companion animals benefit from higher consumer spending, while the Domesticated segment is driven by the rising demand for high-quality veterinary services for livestock. This dual growth presents a unique opportunity for veterinary service providers to expand their offerings and cater to a diverse clientele.

Companion (Dominant) vs. Domesticated (Emerging)

The Companion segment is characterized by a broad range of veterinary services aimed at pets such as dogs and cats, which are seen as family members by their owners. This segment often features routine healthcare, emergency services, and specialty care, leading to high customer loyalty and recurring revenue for veterinary clinics. On the other hand, the Domesticated segment, focusing on farm animals and livestock, is emerging as a critical area of growth. This segment demands specialized veterinary services, with an emphasis on preventive care and disease management. As more producers recognize the economic benefits of maintaining the health of their animals, the interest in veterinary services for this segment is rapidly increasing.

### By Product: Drugs (Largest) vs. Vaccines (Fastest-Growing)

In the US veterinary medicine market, the product segment is dominated by drugs, which hold the largest share. This dominance can be attributed to the increasing prevalence of chronic diseases in pets and the growing expenditure on companion animals. Meanwhile, vaccines are experiencing rapid growth, fueled by heightened awareness about pet health and the importance of preventive care. Consequently, the demand for vaccines is expected to surge as pet owners prioritize vaccination to avoid diseases. Growth trends indicate that the drugs segment will continue to maintain its position due to ongoing innovations in pharmaceutical formulations and effective marketing strategies. In contrast, the vaccines segment is projected to expand swiftly as new vaccine technologies emerge and as public health initiatives emphasize vaccinations. The combination of consumer awareness and advancements in veterinary science will likely propel both segments forward in this competitive market.

Drugs: Dominant vs. Vaccines: Emerging

Drugs play a crucial role in the US veterinary medicine market, serving as the primary means for treating a variety of ailments in animals. The extensive range of available formulations, from anti-inflammatories to antibiotics, underscores their dominating presence. Conversely, vaccines are seen as emerging products that are steadily gaining traction. As pharmaceutical companies invest in research and development, new vaccines that target specific diseases are being introduced to the market. Moreover, the growing trend of preventive care among pet owners positions vaccines as an essential element in maintaining animal health. This dual dynamic characterizes the ongoing landscape, with drugs firmly established as the dominant segment and vaccines carving a significant place as essential preventive measures.

### By Route of Administration: Oral (Largest) vs. Parenteral (Fastest-Growing)

In the US veterinary medicine market, the distribution of market share between the oral and parenteral routes of administration showcases a significant preference for oral medications, which are widely adopted due to their ease of use and convenience for pet owners. Oral medications account for a larger segment of the market, being favored for routine treatments and preventative care, resulting in a strong foothold in the overall market landscape. On the other hand, the parenteral route is witnessing rapid growth, driven by advancements in veterinary practices and the increasing demand for effective and prompt therapeutic interventions. The rise in chronic conditions requiring injectable treatments, coupled with improved formulations, is propelling the parenteral segment as the fastest-growing area within the market, attracting investments and innovations.

Oral (Dominant) vs. Parenteral (Emerging)

The oral route of administration stands as the dominant choice in the US veterinary medicine market, appealing to both veterinarians and pet owners due to its simplicity and non-invasive nature. Oral medications are commonly utilized for a variety of indications, including chronic conditions and preventive care, allowing for easy dosing and administration. In contrast, the parenteral route, although less prevalent, is emerging due to its effectiveness in delivering rapid, high-concentration doses directly into the bloodstream. Parenteral medications are particularly vital in emergency situations and for managing severe health issues. As veterinary technology progresses and client preferences evolve, the parenteral segment is expected to continue gaining traction, showcasing its potential in specialized treatments.

### By Distribution Channel: Veterinary Hospitals & Clinics (Largest) vs. Online Pharmacies (Fastest-Growing)

In the US veterinary medicine market, the distribution of market share among various channels showcases Veterinary Hospitals & Clinics as the prevailing segment, holding the largest share. This dominance is attributed to their extensive reach, established relationships with pet owners, and the ability to provide comprehensive services. Retail Stores also contribute significantly, but their share is gradually decreasing as consumer habits shift toward online options, while Online Pharmacies are rapidly gaining traction in the competitive landscape. The growth trends within this segment highlight a significant shift towards digitalization, particularly for Online Pharmacies, which are currently the fastest-growing channel. Factors such as convenience, competitive pricing, and an expanding range of veterinary products available online are driving this change. Additionally, the COVID-19 pandemic has accelerated the adoption of online services, thereby transforming traditional purchasing behaviors in the veterinary sector.

Veterinary Hospitals & Clinics (Dominant) vs. Online Pharmacies (Emerging)

Veterinary Hospitals & Clinics are firmly established as the dominant distribution channel, renowned for their direct patient interaction and the ability to provide personalized care. This channel benefits from the trust pet owners place in their local veterinarians, ensuring repeat business and loyalty. In contrast, Online Pharmacies are emerging as a disruptive force in the market, leveraging technology to offer convenience and a broad selection of products. They cater to a tech-savvy consumer base seeking ease and accessibility, making them particularly appealing. This shift not only complements traditional channels but also reflects changing consumer preferences towards more efficient purchasing solutions for veterinary care.

## Competitive Benchmarking

The veterinary medicine market in the US is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on digital transformation. Key players such as Zoetis (US), Merck Animal Health (US), and Elanco Animal Health (US) are at the forefront of this dynamic environment. Zoetis (US) has positioned itself as a leader through its commitment to research and development, focusing on advanced biologics and diagnostics. Meanwhile, Merck Animal Health (US) emphasizes its broad portfolio of vaccines and pharmaceuticals, aiming to enhance animal health and productivity. Elanco Animal Health (US) is also notable for its strategic acquisitions, which bolster its product offerings and market reach, thereby intensifying competition among these major players.The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing processes. The market structure appears moderately fragmented, with several key players exerting considerable influence. This fragmentation allows for a diverse range of products and services, catering to various segments within the veterinary medicine market. The collective strategies of these companies not only enhance their competitive positioning but also contribute to a more resilient supply chain, which is crucial in meeting the evolving demands of the market.
In October Zoetis (US) announced a strategic partnership with a leading technology firm to develop AI-driven diagnostic tools aimed at improving disease detection in livestock. This initiative is significant as it underscores Zoetis's commitment to integrating cutting-edge technology into its product offerings, potentially enhancing its competitive edge in the market. The collaboration may also facilitate faster and more accurate diagnostics, which are essential for effective disease management in veterinary practices.
In September Merck Animal Health (US) launched a new vaccine aimed at combating a prevalent viral disease in companion animals. This product introduction is crucial as it not only expands Merck's portfolio but also addresses a significant health concern among pet owners. The timely release of this vaccine could strengthen customer loyalty and enhance Merck's market share, particularly in the growing segment of pet healthcare.
In August Elanco Animal Health (US) completed the acquisition of a smaller biotech firm specializing in innovative treatments for parasitic infections in livestock. This acquisition is strategically important as it allows Elanco to diversify its product line and enhance its research capabilities. By integrating these new technologies, Elanco may improve its competitive positioning and respond more effectively to the needs of livestock producers.
As of November the veterinary medicine market is witnessing trends that emphasize digitalization, sustainability, and the integration of AI technologies. These trends are reshaping competitive dynamics, with companies increasingly forming strategic alliances to leverage shared expertise and resources. The shift from price-based competition to a focus on innovation and technology is evident, as firms prioritize the development of advanced solutions that enhance animal health and operational efficiency. Looking ahead, competitive differentiation is likely to evolve further, driven by the need for reliable supply chains and innovative product offerings that meet the demands of a rapidly changing market.

## Recent News & Developments

Recent developments in the US Veterinary Medicine Market reflect significant activity among key players such as Zoetis, Merck Animal Health, and Elanco Animal Health. In October 2023, Zoetis announced the launch of a new portfolio of mRNA-based vaccines aimed at enhancing disease resistance in livestock. The market is also witnessing a noteworthy surge in investment; for instance, MediVet Biologics received funding in September 2023 to expand its regenerative medicine offerings for pets.

In terms of mergers and acquisitions, Merck Animal Health completed the acquisition of a biotechnology firm specializing in animal health in August 2023, strengthening its position in the diagnostics sector. Meanwhile, in July 2023, Elanco Animal Health announced its merger with a veterinary service provider to enhance its service capabilities across the US.

The valuation of companies has seen a marked increase due to rising pet ownership, with IDEXX Laboratories reporting revenue growth attributed to strong demand for diagnostic products. Over the last couple of years, heightened focus on animal welfare and advances in veterinary technology continue to reshape the landscape of the US Veterinary Medicine Market.

## Report Scope

| MARKET SIZE 2024 | 8.87(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 9.37(USD Billion) |
| MARKET SIZE 2035 | 16.18(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.62% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Virbac (FR), Ceva Santé Animale (FR), Dechra Pharmaceuticals (GB), Vetoquinol (FR), Phibro Animal Health (US) |
| Segments Covered | Animal Type, Product, Route of Administration, Distribution Channel |
| Key Market Opportunities | Integration of telemedicine and digital health solutions in the veterinary medicine market. |
| Key Market Dynamics | Rising demand for advanced veterinary therapeutics drives innovation and competition in the veterinary medicine market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the overall market valuation of the US veterinary medicine market in 2024?**
A: The overall market valuation was $8.87 Billion in 2024.

**Q: What is the projected market valuation for the US veterinary medicine market by 2035?**
A: The projected market valuation for 2035 is $16.18 Billion.

**Q: What is the expected CAGR for the US veterinary medicine market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during 2025 - 2035 is 5.62%.

**Q: Which companies are considered key players in the US veterinary medicine market?**
A: Key players include Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, and others.

**Q: What were the valuations for the companion animal segment in 2024 and its projected value in 2035?**
A: The companion animal segment was valued at $5.32 Billion in 2024 and is projected to reach $9.73 Billion by 2035.

**Q: How did the valuation of the drugs segment change from 2024 to the projected value in 2035?**
A: The drugs segment was valued at $5.31 Billion in 2024 and is projected to grow to $9.12 Billion by 2035.

**Q: What are the projected values for the oral and parenteral routes of administration by 2035?**
A: The oral route is projected to reach $6.45 Billion, while the parenteral route is expected to reach $9.73 Billion by 2035.

**Q: What were the distribution channel valuations for veterinary hospitals and clinics in 2024?**
A: In 2024, the valuation for veterinary hospitals and clinics was $3.55 Billion.

**Q: What is the projected value for online pharmacies in the US veterinary medicine market by 2035?**
A: The projected value for online pharmacies by 2035 is $4.79 Billion.

**Q: How does the valuation of the retail stores segment compare between 2024 and 2035?**
A: The retail stores segment was valued at $2.66 Billion in 2024 and is projected to grow to $4.83 Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-veterinary-medicine-market-12955*